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ABSTRACT
￿
Myelin sheaths of rapidly growing rats were sequentially labeled with the 3H and
"C isotopes of leucine as precursors of protein synthesis. The two injections were separated by
time intervals ranging from 2 to 12 d. Wallerian degeneration was initiated by sciatic nerve
neurotomy at 2 or 10 d after the second injection of radioactivity. After 5 d of degeneration,
myelin was purified and the ratio of isotopes was determined in the delipidated protein.
Regardless of the order in which the two isotopes were administered, the relative recovery of
radioactivity resultant from the second injection was greatly reduced in degenerating nerves
compared with sham-operated controls. Radioactivity incorporated from the first injection was
also reduced, but to a lesser extent. Consequently, the isotope ratio corresponding to the first/
second injection was greater in degenerating nerves than in controls, and the ratio increased
in proportion to the time interval separating the two injections. The magnitude of the effect of
degeneration was only slightly greater when degeneration was initiated 2 d after the second
injection than when initiated 10 d after the last injection. Consequently, myelin disintegration
rather than diminished incorporation of radioactivity accounts for the losses of radioactivity.
Furthermore, the pattern of myelin degeneration preferentially involves the last myelin to be
formed .
Peripheral nerve lesions resulting from nerve transection, nerve
crush, or severe compression lead to a characteristic and repro-
ducible degeneration of the nerve commonly referred to as
Wallerian degeneration (for reviews, see references 21 and 31).
These observations include primary effects, such as the accu-
mulation of organelles in paranodal axoplasm (10, 22, 34, 45)
and loss of axoplasmic microtubules and neurofilaments (10,
13, 20, 32, 33), and secondary effects involving myelin and
Schwann cells. In the latter category, effects appear as early as
12 h, and observations include an increase in the number of
Schmidt-Lantermann clefts, a loosening of the myelin lamellae
(24, 34), and retraction ofmyelin loops at the nodes of Ranvier
(4, 28). After 3 d of axon degeneration, segmentation of myelin
appears paranodally (26) and myelin debris appears in
Schwann cells (26, 28, 32). During the 1st wk of degeneration,
Schwann cells show increased numbers of cell organelles (24,
26, 32) and an increased amount of cytoplasm (4, 28, 44).
Dissolution of the axon and breakdown of myelin are accom-
THE JOURNAL OF CELL BIOLOGY " VOLUME 87
￿
OCTOBER 1980
￿
1-5
©The Rockefeller University Press - 0021-9525/80/10/0001/05$1 .00
panied by a proliferation of Schwann cells, starting at -4 d in
the rat and rabbit (1, 2, 6, 11, 28, 32).
The rapid loss of peripheral nerve myelin as a result of
Wallerian degeneration is well known (2, 5, 25, 32, 43), and
various studies have demonstrated increased proteinase and
lysosome activity in peripheral nerves undergoing Wallerian
degeneration (3, 17-19, 29, 37). Because degenerative axonal
changes appear to precede myelin breakdown in Wallerian
degeneration, Wolman (42) proposed that the increased lyso-
somal activity in axons was the source of enzymes leading to
demyelination. For such cases, he proposed the term "centrif-
ugal demyelination" to denote a process whereby the direction
ofmyelin degeneration is from the axon out through the myelin
layers. For neuropathies in which myelin breakdown precedes
axonal pathology; Wolman proposed the term centripetal de-
myelination to denote probable degeneration from the outside
inward.
Various morphological and biochemical studies of Schwanncellsindicate that new (most recently synthesized) myelin layers
are laid down upon existing layers (12, 14, 15, 30, 36) to form
a growing spiral. Thus myelin growth is highly ordered in the
developing rat and involves both the addition of new myelin
spirals and an elongation of the internode width as well.
Consequently, we alternately tagged myelin growth with 3H
and 14C isotopes of leucine to test hypotheses that myelin
breakdownduringWalleriandegeneration proceeds by pattern.
MATERIALS AND METHODS
Both 1.-[4,5'Hlleucine, 50 Ci/mmole, and t.-[l-1"C]leucine, 290 mCi/mmol, were
purchased from New England Nuclear (Boston, Mass.). Isotope solutions were
evaporated under a stream of nitrogen, redissolved in water, redried through
several cycles to remove traces of hydrochloric acid, and reconstituted in phos-
phate (0.01 M) -buffered physiological saline (pH 7.2). Isotope administration
was by intraperitoneal injection. Doses in all cases were 1 .0 pCi of[I"Clleucine/
g body weight, and 3.01LCi of ['Hlleucine/g body weight.
Pregnant rats were obtained from Charles River Co. (Boston, Mass.). The
offspring were used to radioactively label myelin synthesis in vivo, starting at 12
d of postnatal age, as growth and sciatic nerve myelination are rapid at this time
(40). The'H and 1"C radioactive isotopes of leucine were administered one at a
time and separated by intervals ranging from 2 to 12 d, presumably tagging the
growing myelin spiral withalternate layers of'H and1"C radioactivity. The order
of myelin loss was determined by measuring ratios ofthe two isotopes in myelin
purified from degenerating nerves. In every experiment (e.g., Fig. l), controls
included the use ofanimals injected in the reverse order as well as sham-operated
rats.
At 2 or 10 dafter the administration ofsecond isotope, rats were anesthetized
with pentobarbital, and surgical neurotomy was performed on the left sciatic
nerve just distal to the sciatic notch ofthe pelvis. Sham surgery was performed
on the right side. An additional control included rats having sham surgery on
both sides. Sham surgery consisted of exposing the sciaticnerveas ifit were to be
cut. Surgical incisions were closed with wound clips. After 5 d of Wallerian
degeneration, which we have shown results in a 30-50% decrease in myelin
recovery (5), rats were killed by decapitation and myelin was purified from the
distal 1.7-cm segments of individual sciatic nerves. At the ages used, a 1.7-cm
segment constitutes essentially the full weightand length ofthe nerve in the lower
extremity, and thus various data are reported as disintegrations per minute per
nerve myelin. Myelin was purified on discontinuous sucrose gradients by ultra-
centrifugation, osmotically shocked, and repurified as we have previously de-
scribed (38-40).
Freeze-dried myelin was delipidated by three cycles of extraction with ether:
ethanol (3:2, vol/vol). Polyacrylamide disc gels ofmyelin protein were prepared
as described previously (38, 40). Freeze-dried myelin protein was digested in
Protosol (New England Nuclear) and liquid scintillation countingwas performed
in toluene containing Omnifluor (New England Nuclear) as describedpreviously
(39). A Searle Mark III counter (Searle Radiographics Inc., Des Plaines, Ill.), or
a Beckman 9000 (Beckman Instruments, Inc., Fullerton, Calif .), were employed
with essentially identical results. Tritium spillover into the1"C channel was 1-2%.
1"C spillover into the tritium channel was 13-18%. Counts per minute were
detected at efficiencies of --37% for tritium and 74%for 1"C; counts per minute
were automatically computed as disintegrations per minute. All averaged data
show the standard error of the mean. All isotope ratio values are ratios of
disintegrations per minute. Isotope ratios are expressed as the ratio of the first
administered isotope to the second.
RESULTS
In control studies, therelative incorporation of [3H]leucine and
14C radioactivity into sciatic nerve myelin protein of 12-d old
rats was determined by injecting 19 rats intraperitoneally with
a 3:1 mixture of [3H]leucine and [1"C]leucine. Rats were sacri-
ficed at times ranging from 2 h to 14 d later, and the ratio of
14C/3H radioactivity was determined for delipidated myelin
protein. The relative incorporation of 14C radioactivity into
sciatic nerve delipidated myelin protein exceeded 3H by 27%,
resulting in a constant 14C/3H ratio of 0.422 ± 0.006 over a
period of 2 wk after the injection. However, the accumulation
of total radioactivity in myelin increased for up to 10 d after
the injection (Fig. 2). The appearance of a decline in radioac-
tivity after 2-3 wk, presumably from turnover, has been sub-
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FIGURE 1
￿
The experimental regimen. Rats 1-6 were injected with
[1_14C]leucine at an age that varied between the interval of 12-22
d. Each rat was injected with [4,5-3H]leucine on day 24. Rats num-
bered 7 and 8are reverse isotope controls. As a result of this labeling
regimen, the growing myelin sheath will include an inner zone
labeled with the first isotope and outer lamella labeled with the
second of the two isotopes. At the age of 26 d (2 d after the 2nd
isotope injection), surgery was performed on each rat. Left sciatic
nerves were cut to initiate Wallerian degeneration; right sciatic
nerves were sham operated. At 5 d after surgery, myelin was pre-
pared from each sciatic nerve. See text for additional details of the
experimental design .
6 myelin protein
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FIGURE 2
￿
The top panel shows the 1 "C/3H ratio of radioactivity in
delipidated myelin protein of rat sciatic nerve after the injection of
1:3 mixture of ['"Clleucine and [3Hlleucine, intraperitoneally, at 12
d of age. The bottom panel shows the increase in radioactivity
(using the ['"Cl data) for up to 2wk after these injections.
stantiated elsewhere.'
Because the studies of patterned degeneration (to follow)
involve sequential administrations of the two isotopes over
several days andsubsequent surgery, we also examined isotope
ratios in control rats injected at different times. Three rats
received ['4C]leucine at 18 d of age, followed by ['H]leucine at
24 d (in a 1:3 ratio, by body weight). 2 d later, sham surgery
was performed on the sciatic nerves of each rat, and rats were
killed at 3, 5, and 7 d after the second injection. The 14C/3H
ratio of sciatic nerve myelin protein in each case was: 0.59,
0.46, and 0.44, respectively. Theseratiodata are consistent with
'Unpublished data from thelaboratory of Dr. Wiggins.the time-course for incorporation (Fig. 2) and show that incor-
poration of the second injection was almost complete by 7 d,
as the ratio at this time is within 5% of the ratio (0.42) obtained
by injection of the two isotopes simultaneously (Fig. 2). Fur-
thermore, sham surgery did not alter the incorporation of
radioactivity into sciatic nerve myelin protein.
The effect of Wallerian degeneration on the recovery of
myelin radioactivity was examined for the case where surgical
neurotomy (to initiate degeneration) occurs at 2 d after the
second injection (during the period of rapid incorporation of
radioactivity into compact myelin) and at 10 d after the second
injection (when incorporation ofradioactivity should be essen-
tially complete, see Fig. 2). In the first experiment(Fig. 1), the
typical order of administration was [14C]leucine followed by
[3H]leucine; in the second experiment, the order was [3H]leucine
followed by [14C]leucine. As an additional control for isotope
effects, the order was also reversed within each set. Equivalent
results were obtained in all cases.
In the first experiment, rats were killed for myelin prepara-
tion at 17 d after the 14C injection and 7 d after the final 3H
injection. In the case of sham-operated nerves,
14C averaged
360 ± 25 dpm/nerve myelin and 3H averaged 850 ± 79 dpm/
nerve myelin. The ratio of radioactivity in sham-operated
nerves increased slightly from 0.40 to 0.51 (Fig. 3) as the
interval between injections increased (see Fig. 1), indicating
slightly more complete incorporation of the radioactivity from
the first injection relative to the second at the time of sacrifice.
The ratio values observed here for the sham-operated nerves
are essentially the same as in the preliminary control studies
above.
However, for nerves undergoing 5 d of Wallerian degenera-
tion, results are quite different from those observed in the
corresponding sham-operated nerves. The recovery of myelin
protein labeled by both the first and second injections of
radioactive leucine was greatly decreased compared to sham-
operated controls, but more importantly, the loss of radioactiv-
ity resulting from the second injection (occurring 2 d before
surgery) was greater than for myelin labeled by the first injec-
tion. Consequently, as the interval separating the two injections
increased from 2 to 12 d, the ratioofthe first/second injections
increased by twofold (Fig. 3). The recovery of radioactivity
representing myelin protein synthesis at 14, 10, 6, and 4 d
before neurotomy (14C data) was 170, 161, 125, and 89 dpm/
nerve. Compared to the incorporation of radioactivity and
myelin recovery from the paired sham-operated nerves, these
"C values represent recoveries ranging from 47% for myelin
protein synthesized 14 d before neurotomy, to 25% for myelin
protein synthesized 4 d before neurotomy. The recovery of 3H-
labeled myelin protein, representing synthesis 2 d before neu-
rotomy, was 173 ± 9 dpm/nerve, or 22 ± 1% of the recovery
in paired sham-operated nerves. A similar effect was obtained
with the reverse isotope controls (Fig. 3). In this experiment,
surgery to initiate degeneration occurred 2 d after administra-
tion of the second isotope, and consequently it is not clear
whether degeneration caused a preferential loss of myelin
labeled by the second injection, or reduced incorporation of
radioactivity from the second injection. Therefore, a second
experiment was designed in which surgery followed the final
injection by a period sufficient to afford complete incorporation
(see Fig. 2).
In the second experiment, [3H]leucine was administered on
day 12, ["C]leucine on day 24, surgery was performed on day
34, and rats were killed on day 39. The order of isotope
administration is the same as for the reverse isotope controls
(Figs. 1 and 3). The resultant 3H/14C ratio for sham-operated
nerves was 2.5 ± 0.2, essentially the same as in Fig. 3. The 3H/
14C ratio in paired degenerating nerves was 3.9 ± 0.3, an
increase of 1.6-fold over the ratio in paired sham-operated
nerves, again as a result of preferential loss of the second label.
The radioactivity observed in myelin of sham-operated nerves
was 304 ± 38 dpm/nerve for 3H and 123 ± 23 dpm/nerve for
14C.In the paired degenerating nerves, recovery ofradioactivity
resulting from the first injection, 3H, was 204 ± 52 dpm/nerve,
or 71 ± 20%; recovery ofradioactivity resulting from the second
injection,
14C, was 56 t 13 dpm/nerve, or 52 ± 12%. Thus,
preferential loss of the most recently formed myelin, not a
reduction in incorporation, accounts for the altered ratios in
myelin protein of degenerating nerves.
The protein composition of myelin recovered during Wal-
lerian degeneration was examined by polyacrylamide gel elec-
trophoresis. Adult rats were used because of the very low
recoveries of myelin from degenerating nerves (5), com-
pounded by the small size of young rats (40). Results (Fig. 4),
show no marked alteration of the myelin protein composition
after 1, 3, or 5 d ofWallerian degeneration. Additional analyses
by Bell (5) confirm this conclusion.
DISCUSSION
The present study indicates that the peak of incorporation of
leucine radioactivity into sciatic nerve myelin of young rats
occurs at 10-12 d after intraperitoneal administration of leu-
cine, and the relative incorporation of "C radioactivity into
normal sciatic nerve myelin protein slightly exceeded (by 27%)
0.8
0.4
0.2
0
. 1
C) followed by [3H]
12 10 B 6 4 2 0
INTERVAL (days)
Between a 14C and a 3H pulse label
FIGURE 3 The ratio of radioactivities, recovered in myelin, that
result from the first and second isotope injections. Animal numbers
correspond to the rats described in Fig. 1 . For rats 1-6, the ' 4C/3H
ratio is the first (injected) isotope divided by the second; for rats 7
and 8, the 3H/'4C ratio is the first divided by the second . The asterisk
shows the ratio for normal myelin after the injection of a (3:1)
mixture of [3H]leucine and [14C]leucine. The isotope ratio in sham-
operated control nerves is similar. For degenerating nerves, the ratio
represented by the radioactivity of the first injection/second injec-
tion increases as the time between the two injections increases.
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o14C radioactivity has been previously observed and discussed
(39) . Because leucine, administered as a protein precursor, is in
an active metabolic pool (23) having a half-life measured in
minutes, we may conclude that myelin protein synthesized at
the time of the injection (and thus radioactively tagged) re-
quires several days to complete its eventual incorporation into
compact myelin lamellae . The observations and conclusions
appear consistent with autoradiographic studies ofglycoprotein
incorporation into peripheral nerve myelin (14) .
The initiation of Wallerian degeneration in sciatic nerves
previously tagged by injections of radioactive leucine reveals
two major effects on myelin. First, by comparing equivalent
results in sham-operated nerves, the amount of radioactively
FIGURE 4
￿
Polyacrylamide disc gels showing the protein composi-
tion of sciatic nerve myelin at 0 (control), 1, 3, and 5 d after surgical
neurotomy to initiate Wallerian degeneration . Each gel is loaded
with 50 Fig of protein and stained with Fast Green . (See Discussion
for a description of the band identification .)
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labeled protein is greatly reduced in degenerating nerves . How-
ever, the amount of the reduction depends on the time interval
between administration of the radioactive precursor and the
onset of degeneration. 5 d of Wallerian degeneration was
observed to reduce radioactivity by 80% when the isotope
injection preceded surgery by only 2 d and by only 29% when
the injection preceded surgery by 22 d . Thus, the total myelin
loss was extensive ; however, loss of the most recently synthe-
sized myelin was greatest, as evidenced by the increasing
myelin ratios representing radioactivity of the first/second
injections .
By comparing results of the two degeneration experiments,
it is possible to estimate the relative effects of Wallerian
degeneration on (a) blocking incorporation of radioactively
labeled protein into compact myelin and (b) actual degradation
of radioactively labeled compact myelin . Isolation of these
events is permitted by the requirement ofa time period of - 10
d for full incorporation of leucine radioactivity into compact
myelin. Where surgical neurotomy followed the second injec-
FIGURE 5 A model of sciatic nerve myelin degeneration during
Wallerian degeneration . A shows a normal Schwann cell, several
layers of compacted myelin, and Schmidt-Lantermann clefts (a); 8
shows early stages of myelin catabolism, including an increase in
Schmidt-Lantermann clefts (a), loosening at the interperiod line (b),
and myelin disintegration ; (C) progressive degeneration, showing
axon segmentation (c) andextensive myelin degeneration affecting
the outer lamellae (d) and all layers in association with segmenta-
tion .tion by only 2 d, and the first by 14 d, the ratio representative
of the first/second injections increased by 2-fold over sham
controls after 5 d of degeneration. Where neurotomy followed
the second injection by 10 d, and the first by 22, the ratio in
degenerating nerves increased by 1.5-fold over sham controls.
Thus, comparable effects were obtained in each case, and from
similarity of the two results we can conclude that disruption of
processes leading to myelin assembly cannot account for the
altered isotope ratios observed in myelin of degenerating
nerves. Instead, the loss of radioactivity is the result of actual
myelin disintegration in a pattern that preferentially involves
the most recently formed fractions, which includes the outer-
most lamellae (12, 14, 30), and the lateral loops. Early myelin
loss probably occurs in the Schmidt-Lantermann clefts as well.
On the basis ofthese observations, the hypothesis of centrifugal
demyelination of Wolman (42) is refuted. Experimental results
indicate essentially the reverse, and although the degeneration
process preferentially involves the last assembled lamellae,
extensive myelin loss occurs in layers representative ofsynthesis
at all ages.
In Fig. 5, we present a model of myelin breakdown during
Wallerian degeneration ofthe sciatic nerve. This interpretation
includes features of the histological literature as well as our
biochemical conclusions.
Fig. 5 A represents an axon segment showing a Schwann cell
with several myelin layers. In Fig. 5 B, which represents an
early stage of Wallerian degeneration: (a) myelin lamellae are
loosened along the interperiod line (28) and Schmidt-Lanter-
mann clefts are dilated and increased in number (4, 7, 24, 35,
41); (b) Schwann cell cytoplasm has retracted from the nodes,
leaving small areas of bare axon (9), however, Ballin and
Thomas (4) observed no bare axons in their detailed study of
the nodal region; and (c) myelin disintegration has begun,
especially at the paranodal lamellae (4, 28, 41), the outermost
(most recently formed) layers, and in the Schmidt-Lantermann
clefts.
In Fig. 5 C, (a) progressive disintegration ofthe myelin outer
lamellae continues; (b) axons begin to segment, resulting in a
fragmentation and collapse of the myelin sheath parallel to
areas of shrinkage of the axon (5, 24, 27, 28). Axonal segmen-
tation and collapse of the adjacent myelin lamellae most likely
accounts for much of the myelin loss at inner, as well as outer,
layers.
With regard to electrophoretic characterization of myelin
recovered during Wallerian degeneration, Fig. 4 shows the
persistence of an essentially normal protein composition. Be-
cause myelin recovery is operationally defined, one would
expect little alteration of composition in the "recovered" frac-
tion. Myelin in various stages of degeneration may contribute
to additional subfractions, although no consensus has emerged
with regard to the metabolic significance of myelin subfrac-
tions. The nomenclature for myelin proteins (Fig. 4) is consist-
ent with our current usage (40) and reflects the recent (16)
reevaluation of the small basic protein and P2. Identification of
the Y band is included, although recent evidence indicates that
Y is a function of the state of sample reduction (8).
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